Mensana: what changed
What changed
Mensana
NACE 86.999, Other human health activities
filed annual accounts (NBB)
Net result for the year
-€255
2024 · €15,345-€15,600
Equity
€804
2024 · €1,059-€255
Cash
€804
2024 · €2,066-€1,262
Balance sheet total
€804
2024 · €2,066-€1,262
Largest movements
Assets
- Cash -€1,262
down €1,262 (-61.1%), from €2,066 to €804
mainly Debts within one year (-€1,007) and Net result for the year (-€255)
Equity and liabilities
- Debts within one year -€1,007
no longer reported in 2025 (was €1,007)
- Profit (loss) carried forward -€255
down €255 (-24.1%), from €1,059 to €804
Income statement
- Gross operating margin -€15,631
down €15,631, from €15,500 to -€131
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€15,345
Gross operating margin
-€15,631
Financial charges
+€31
Result 2025
-€255
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€1,262
Investment
€0
Financing
€0
Cash 2024
€2,066
From operations (derived)
-€1,262
Net result for the year
-€255
Debts within one year
-€1,007
Cash 2025
€804
takes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,066 | €804 | -€1,262 | -61.1% |
| Current assets | 29/58 | €2,066 | €804 | -€1,262 | -61.1% |
| Cash at bank and in hand | 54/58 | €2,066 | €804 | -€1,262 | -61.1% |
| Total equity and liabilities | 10/49 | €2,066 | €804 | -€1,262 | -61.1% |
| Equity | 10/15 | €1,059 | €804 | -€255 | -24.1% |
| Profit (loss) carried forward | 14 | €1,059 | €804 | -€255 | -24.1% |
| Amounts payable | 17/49 | €1,007 | - | -€1,007 | |
| Amounts payable within one year | 42/48 | €1,007 | - | -€1,007 | |
| Non-recurring operating income | 76A | €15,500 | - | -€15,500 | |
| Goods, raw materials, services and sundry goods | 60/61 | - | €131 | +€131 | |
| Gross operating margin | 9900 | €15,500 | -€131 | -€15,631 | |
| Operating profit (loss) | 9901 | €15,500 | -€131 | -€15,631 | |
| Financial charges | 65/66B | €155 | €124 | -€31 | -20.0% |
| Recurring financial charges | 65 | €155 | €124 | -€31 | -20.0% |
| Profit (loss) for the period before taxes | 9903 | €15,345 | -€255 | -€15,600 | |
| Profit (loss) for the period | 9904 | €15,345 | -€255 | -€15,600 | |
| Profit (loss) for the period to be appropriated | 9905 | €15,345 | -€255 | -€15,600 |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.